NTIC Northern Technologies International Corporation

NASDAQ
$7.52

NTIC Delivers Record Sales but Misses on Earnings Again as the Profitability Promise Slips

Northern Technologies International delivered the top line investors wanted but not the bottom line. Fiscal fourth-quarter revenue rose 18.6% year over year to a record $26.46 million, beating the $25.2 million consensus by 5.0%. The company still reported an adjusted loss of $0.06 per share against a consensus estimate of a $0.06 profit, a 200.0% miss. Earnings growth was 0.0% because the adjusted loss matched the prior-year quarter. On a GAAP basis, the net loss narrowed to $642,000, or $0.07 per share, from $1.1 million, or $0.12. That central tension has now defined NTIC for several quarters: demand keeps strengthening, and almost none of it reaches shareholders.

The quality of the quarter deserves scrutiny. Gross profit rose to $9.25 million, but gross margin fell to 35.0% from 37.9% a year earlier. Management cited raw material costs for resin and solvents that were only partly passed through, lower Natur-Tec pricing, and a weaker mix. Operating leverage was real: operating expenses fell to 39.0% of sales from 43.5% as revenue outgrew a 6.4% expense increase. Operating income nonetheless dropped to $504,000 from $929,000. Income from joint-venture operations fell 27.7% to $1.57 million, reflecting reduced fees after modifications at EXCOR and Acobal and weaker EXCOR profitability, which the call tied to one-time charges and softer revenue in Germany. Below the operating line, a $813,000 tax charge on just $393,000 of pre-tax income turned a small profit into a loss. For the full year, the effective tax rate reached 86.3%, driven partly by a full valuation allowance against U.S. deferred tax assets. NTIC went from essentially breakeven in fiscal 2025 to a $703,000 GAAP loss in fiscal 2026.

The operating trends beneath the headline are better than the earnings suggest. Sales growth accelerated for a third straight double-digit quarter, from 15.3% in Q2 and 12.6% in Q3 to 18.6% in Q4. ZERUST industrial grew 24.3%, up from 10.3% in Q3. Natur-Tec grew 23.0%, up from 5% in Q3. Gross margin also recovered sequentially from 33.6% in Q3. The weak spot was oil and gas. That business set a full-year record of $9.8 million, but Q4 sales fell 16.5% after growing 72% in both Q2 and Q3. The causes were Middle East conflict affecting clients and a pause in Brazil FPSO preservation work, and management said the Middle East drag continues into the first quarter. Joint-venture sales growth also slowed sharply to 4.0% from 15.1% in Q3.

Credibility is now as important as the numbers. On the Q3 call, management promised a stronger, more profitable fourth quarter and pointed to invoiced June oil and gas projects. Instead, the net loss widened from $263,000 in Q3. New CEO Gautam Ramdas, previously head of ZERUST oil and gas, replaced the prior "temporary pressure" framing with an explicit admission that profitability has not kept pace. His plan includes:

  • adopting EPS as the primary management KPI;
  • merging ZERUST industrial and oil and gas into one division to eliminate duplicated R&D;
  • tightening receivable terms;
  • launching the Zerust Integrity Solutions offering for tanks, pipelines, FPSOs and data centers.

Management expects a "much stronger" fiscal 2027, further gross margin recovery in Q1 and U.S. operating expenses up only 3% to 4%. Analysts pressed on returns, however, and no quantified targets were offered.

The balance sheet gives bears legitimate ammunition. Revolver borrowings rose to $11.1 million from $9.3 million, and total debt climbed to about $14.2 million from $12.2 million, while cash slipped to $7.0 million. The release discloses noncompliance with a financial covenant at the end of both the third and fourth quarters, along with near-term maturity of the revolving credit facility. Several pending items should provide relief:

  • the French joint venture's shift from royalties to dividends, with roughly EUR 2 million expected around late November or early December;
  • the Beachwood facility sale at $1.1 million, now with a new buyer after the original agreement collapsed, though the buyer can still walk away during a 60-day inspection period;
  • joint-venture investments of $30.7 million, of which $18.1 million is cash, representing value that is not consolidated.

The market had already priced in skepticism. Shares closed at $7.52 before the report, down 9.1% from the $8.27 opening after the July release. That price sat just 1.6% above the inter-earnings low of $7.40 set on November 6 and 13.9% below the August high of $8.74. Price and AVWAP trend readings are negative. Investor sentiment was essentially neutral, edging up from 0.016 to 0.032, which suggests expectations were muted rather than hostile.

The bottom line is that NTIC's growth engine is working, with accelerating industrial and Natur-Tec demand and record sales, while its earnings engine is not. Margin compression, shrinking joint-venture fees, a punitive tax structure and rising debt continue to absorb the revenue gains. The new CEO has said the right things, but after another missed profitability promise and no hard targets, investors will likely need to see the French dividend arrive, covenant and refinancing issues resolved, and EPS finally turn positive before the record top line earns much credit.

← Back to NTIC news

Read our preview of this report →